These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19275269)

  • 1. Tumour vaccine approaches for CNS malignancies: progress to date.
    Ebben JD; Rocque BG; Kuo JS
    Drugs; 2009; 69(3):241-9. PubMed ID: 19275269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide vaccine.
    Izumoto S
    Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic-cell- and peptide-based vaccination strategies for glioma.
    Yamanaka R
    Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine strategies for glioblastoma: progress and future directions.
    Jackson C; Ruzevick J; Brem H; Lim M
    Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
    Akasaki Y; Black KL; Yu JS
    Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-based immunotherapeutic approaches to glioma: a review.
    Yamanaka R; Itoh K
    Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine therapies in malignant glioma.
    Oh T; Sayegh ET; Fakurnejad S; Oyon D; Lamano JB; DiDomenico JD; Bloch O; Parsa AT
    Curr Neurol Neurosci Rep; 2015 Jan; 15(1):508. PubMed ID: 25431096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.
    Wang X; Zhao HY; Zhang FC; Sun Y; Xiong ZY; Jiang XB
    Cancer Invest; 2014 Nov; 32(9):451-7. PubMed ID: 25259676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell immunotherapy for malignant gliomas.
    Luptrawan A; Liu G; Yu JS
    Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer vaccines: an update.
    Hipp JD; Hipp JA; Lyday BW; Minev BR
    In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell based vaccination strategy: an evolving paradigm.
    Filley AC; Dey M
    J Neurooncol; 2017 Jun; 133(2):223-235. PubMed ID: 28434112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of diffuse gliomas: biological background, current status and future developments.
    Grauer OM; Wesseling P; Adema GJ
    Brain Pathol; 2009 Oct; 19(4):674-93. PubMed ID: 19744040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in active-specific immunotherapy of brain malignancies.
    Tjoa BA; Salgaller ML
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2093-101. PubMed ID: 11060795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug or vaccine?: selecting the appropriate treatment for malignant glioma patients.
    Dai XJ; Jiang WJ; Wang WM; Zhao SJ
    Drugs; 2010 Aug; 70(12):1477-86. PubMed ID: 20687616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell vaccines.
    Yamanaka R; Kajiwara K
    Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunotherapeutic approaches to glioma.
    Yamanaka R
    Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapeutic approaches for glioma.
    Okada H; Kohanbash G; Zhu X; Kastenhuber ER; Hoji A; Ueda R; Fujita M
    Crit Rev Immunol; 2009; 29(1):1-42. PubMed ID: 19348609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioma immunology and immunotherapy.
    Parney IF; Hao C; Petruk KC
    Neurosurgery; 2000 Apr; 46(4):778-91; discussion 791-2. PubMed ID: 10764250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.